Covid-19 vâta tlâhleipa pasa tu leipazy châta thohna 'FabiFlu' taopapua haw!
Nohchareih hri kiahpa ama pôh chahra via lymâna hryta, India liata Covid-19 adyuhna kyh liata thâtih lychhihpa tlôpa tlôpa ta, thohna taopapuatuhpa Glenmark Pharmaceuticals Limited chata Covid-19 vâta tlâhleipazy mohôhna thohna Favipiravir, a nie ta niepa chi thohna hmô (tablet), 'FabiFlu' tahpa ta a moh ama bipa cha zawpi chalei thei awpa ta palâhâhpa ta, India liata (COVID-19) hri kiahpa, pasa paru tu leipazy mohôhna châta hmâ thei awpa ta chalei theipa a châ haw.
India râh liata Covid-19 hri-ohpa 80% zy cha ama pasana paru tu muarua leipa châ via chai ei ta. FabiFlu he India liata Covid-19 thohna taopapua tua chaipa a châ, tahpa he thohna taotuhpa Company heta ama rei pâ hra.
“India liata COVID-19 adyuhna sie haipa châta he he chhâhchabi peimawh kawpa châ ta. Glenmark ta he adyuhna liata hmia â sah hai. He daihti he sôhpaliena daihti ryhpaohpa hawhta pachâ leipa pi ta. Eima pachâ peimawh chaipa cha tlâhleipazy châta thohna hmô thei awpa ta taopa nata hrona pachhapa he a châ,” tahpa ta Sujesh Vasudevan, president, India Formulations, Middle East and Africa, Glenmark Pharmaceuticals Limited chata Video conference liata a rei.
Chutyhnoh khata Glenmark Company heta India liata thohna lâchhâh biehneituhpa tawhta he thohna, Favipiravir taopapua awpa pasaina nata, zuah papua awpa pasaina chhao ama hnei ha, ama ta.
Pachyhnoh zâlâ tawhna khata he thohna he Glenmark Company yna bia chhôh liata cha chalei theipa châ ha ta; India râh pôhpalôhpa châta deikua noh 7 tawhta noh 10 khô lâta chalei theipa ta a y ha bâ awpazie Company heta ama rei hra.
He thohna he a tlâ (strip)-ta y aw ta, tlâ kha liata hmô 34 ypa ta, tlâ kha he ₹3,500 ta zuapa châ aw ta, hmô kha he ₹103 a châ tahna a châ.
Noh kha hmô 18 nie awpa châ ta, my ta hmô 9 nata zâlâ hmô 9 ta nie awpa a châ. A noh 2-na tawhta deikua hmô 4 ta nie awpa châ aw ta. Noh 14 chhôh nie awpa a châ. He thohna he Covid-19 vâta tlâhleipa kô 18 tawhta kô 75 taihta nie theipa a châ aw.
A nie ta niepa chi a châpa vâta tlâhleipa châta O liata yna chôta ano khota nie thei ta. Atahmâ duasu liata he thohna he India râh su 11 liata tlâhleipa 150-zy ta ama nie ngâhai. Âmo he he thohna mopachhina châta hmâpa ama châ.
“Russia, Japan nata China liata he thohna Favipiravir mopachhina hneipa liata cha he thohna heta hri raihria athata pachyhsa ta, chasipa pahnai chatlie via ta, husona pazie-ysa chatlie ta, tlâhleipa a patlâhsa chatlie via hra,” tahpa ta Dr Monika Tandon, VP, Head, Clinical Development, Glenmark chata a rei.
- THE HINDU
India râh liata Covid-19 hri-ohpa 80% zy cha ama pasana paru tu muarua leipa châ via chai ei ta. FabiFlu he India liata Covid-19 thohna taopapua tua chaipa a châ, tahpa he thohna taotuhpa Company heta ama rei pâ hra.
“India liata COVID-19 adyuhna sie haipa châta he he chhâhchabi peimawh kawpa châ ta. Glenmark ta he adyuhna liata hmia â sah hai. He daihti he sôhpaliena daihti ryhpaohpa hawhta pachâ leipa pi ta. Eima pachâ peimawh chaipa cha tlâhleipazy châta thohna hmô thei awpa ta taopa nata hrona pachhapa he a châ,” tahpa ta Sujesh Vasudevan, president, India Formulations, Middle East and Africa, Glenmark Pharmaceuticals Limited chata Video conference liata a rei.
Chutyhnoh khata Glenmark Company heta India liata thohna lâchhâh biehneituhpa tawhta he thohna, Favipiravir taopapua awpa pasaina nata, zuah papua awpa pasaina chhao ama hnei ha, ama ta.
Pachyhnoh zâlâ tawhna khata he thohna he Glenmark Company yna bia chhôh liata cha chalei theipa châ ha ta; India râh pôhpalôhpa châta deikua noh 7 tawhta noh 10 khô lâta chalei theipa ta a y ha bâ awpazie Company heta ama rei hra.
He thohna he a tlâ (strip)-ta y aw ta, tlâ kha liata hmô 34 ypa ta, tlâ kha he ₹3,500 ta zuapa châ aw ta, hmô kha he ₹103 a châ tahna a châ.
Noh kha hmô 18 nie awpa châ ta, my ta hmô 9 nata zâlâ hmô 9 ta nie awpa a châ. A noh 2-na tawhta deikua hmô 4 ta nie awpa châ aw ta. Noh 14 chhôh nie awpa a châ. He thohna he Covid-19 vâta tlâhleipa kô 18 tawhta kô 75 taihta nie theipa a châ aw.
A nie ta niepa chi a châpa vâta tlâhleipa châta O liata yna chôta ano khota nie thei ta. Atahmâ duasu liata he thohna he India râh su 11 liata tlâhleipa 150-zy ta ama nie ngâhai. Âmo he he thohna mopachhina châta hmâpa ama châ.
“Russia, Japan nata China liata he thohna Favipiravir mopachhina hneipa liata cha he thohna heta hri raihria athata pachyhsa ta, chasipa pahnai chatlie via ta, husona pazie-ysa chatlie ta, tlâhleipa a patlâhsa chatlie via hra,” tahpa ta Dr Monika Tandon, VP, Head, Clinical Development, Glenmark chata a rei.
- THE HINDU
No comments